Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differing definitions of manufacturer.

M E Donawa1

  • 1Donawa and Associates Ltd., Rome, Italy. donawa@srd.it

Medical Device Technology
|June 6, 1998
PubMed
Summary

Medical device manufacturers face varying US and European labeling rules for manufacturer identification. This article details these key differences, especially concerning own-brand labeling under European directives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New FDA draft guidance on premarket submissions.

Medical device technology·2000
Same author

The quality planning conundrum.

Medical device technology·2000
Same author

Drug delivery: the strategic advantage of design controls.

Medical device technology·1999
Same author

Use and recognition of consensus standards in US premarket submissions.

Medical device technology·1999
Same author

An improved draft guidance to process validation.

Medical device technology·1999
Same author

Avoiding unreasonable reliance on subcontractor certification.

Medical device technology·1999

Area of Science:

  • Regulatory Affairs
  • Medical Device Compliance
  • International Trade

Background:

  • Medical device manufacturers operate under distinct regulatory landscapes in the United States and Europe.
  • Labeling requirements, particularly the indication of the manufacturer, differ significantly between these regions.
  • The practice of own-brand labeling under European medical device directives adds complexity.

Purpose of the Study:

  • To outline and compare the differing medical device labeling requirements in the US and Europe.
  • To highlight specific discrepancies related to manufacturer identification on labels.
  • To analyze the implications of these differences for manufacturers engaging in own-brand labeling within Europe.

Main Methods:

  • Comparative analysis of US FDA labeling regulations.
  • Review of European medical device directives and associated guidance on manufacturer labeling.
  • Examination of own-brand labeling practices under European regulations.

Main Results:

  • The US requires specific manufacturer information on device labels.
  • European regulations permit variations, especially with own-brand labeling, creating distinct requirements from US standards.
  • Significant divergence exists in how manufacturer identity must be presented on medical device labels.

Conclusions:

  • Manufacturers must navigate complex, region-specific labeling rules for medical devices.
  • Understanding these differences is crucial for ensuring compliance and market access in both the US and Europe.
  • Harmonization efforts could simplify global medical device labeling, but current disparities necessitate careful attention to detail.

Related Experiment Videos